Decadron and Platelet disorder - a phase IV clinical study of FDA data

Summary:

Platelet disorder is reported as a side effect among people who take Decadron (dexamethasone), especially for people who are female, 60+ old, also take Revlimid, and have Brain neoplasm malignant.

The phase IV clinical study analyzes which people have Platelet disorder when taking Decadron. It is created by eHealthMe based on reports of 46,837 people who have side effects when taking Decadron from the FDA, and is updated regularly.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.

What is Platelet disorder?

Platelet disorder is found to be associated with 317 drugs and 431 conditions by eHealthMe. Check the latest studies of Platelet disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

46,837 people reported to have side effects when taking Decadron.
Among them, 18 people (0.04%) have Platelet disorder.

Among these 18 people:

What is the gender of people who have Platelet disorder when taking Decadron? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Platelet disorder when taking Decadron? *

What are other drugs people take besides Decadron? *

What are other side effects people have besides Platelet disorder? *

Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 7 people, 38.89%
Haemoglobin Decreased: 7 people, 38.89%
Thrombocytopenia (decrease of platelets in blood): 7 people, 38.89%
Haematocrit Decreased: 6 people, 33.33%
Lymphocyte Count Decreased: 6 people, 33.33%
White Blood Cell Count Decreased: 6 people, 33.33%
Red Blood Cell Count Decreased: 6 people, 33.33%
Red Cell Distribution Width Increased: 5 people, 27.78%
Mean Platelet Volume Decreased (less than normal average size of platelet cells in blood): 5 people, 27.78%
Mean Cell Volume Increased (more than normal average red blood cell volume): 5 people, 27.78%

What are the existing conditions these people have? *

Brain Neoplasm Malignant (brain cancer tumour): 5 people, 27.78%
Nausea (feeling of having an urge to vomit): 3 people, 16.67%
Allergic Transfusion Reaction: 3 people, 16.67%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 2 people, 11.11%
Renal Cell Carcinoma (a kidney cancer): 1 person, 5.56%
Pain: 1 person, 5.56%
Neuropathy Peripheral (surface nerve damage): 1 person, 5.56%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 5.56%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Decadron and have Platelet disorder?

- Check whether Platelet disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Decadron:

Decadron (47,210 reports)

Browse all side effects of Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Platelet disorder:

Platelet disorder (317 drugs)

Browse all the conditions that are associated with Platelet disorder:

Platelet disorder (431 conditions)

Related publications that referenced our studies

Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .
Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Decadron) and Decadron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.